Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment

被引:0
|
作者
Xuefei Li
Yi Wang
Ziqiang Chen
Ming Ruan
Can Yang
Maolin Zhou
Ning Li
Lianping Xing
Hao Xu
Ling Yang
Qi Shi
Yongjun Wang
Jinman Chen
Qianqian Liang
机构
[1] Longhua Hospital,Key Laboratory of Theory and Therapy of Muscles and Bones
[2] Shanghai University of Traditional Chinese Medicine,Cardiovascular Department
[3] Spine Institute,Center for Systems Pharmacokinetics
[4] Shanghai University of Traditional Chinese Medicine,Center for Musculoskeletal Research
[5] Ministry of Education (Shanghai University of Traditional Chinese Medicine),Department of Pathology & Laboratory Medicine
[6] Longhua Hospital,undefined
[7] Shanghai University of Traditional Chinese Medicine,undefined
[8] Shanghai University of Traditional Chinese Medicine,undefined
[9] University of Rochester Medical Center,undefined
[10] University of Rochester Medical Center,undefined
关键词
Rheumatoid arthritis; Tumor necrosis factor transgenic mouse (TNF-Tg); Liver and kidney complications; Anti-TNF therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis
    Oliver, James
    Plant, Darren
    Webster, Amy P.
    Barton, Anne
    BIOMARKERS IN MEDICINE, 2015, 9 (06) : 499 - 512
  • [32] THE STEROID SPARING EFFECT OF ANTI-TNF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Smith, Laura-Jane
    Reade, Helen C.
    Sheehan, Nicholas J.
    Dahiya, Sandeep
    RHEUMATOLOGY, 2009, 48 : I66 - I67
  • [33] Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment
    Ruppert, M.
    De Clerck, L.
    van Offel, J.
    Hubens, G.
    Balliu, L.
    Vaneerdeweg, W.
    ACTA CHIRURGICA BELGICA, 2006, 106 (02) : 225 - 227
  • [34] Treatment of rheumatoid arthritis: non anti-TNF antagonists, when and which?
    Mola, Emilio Martin
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 705 - 705
  • [35] Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies
    Bogunia-Kubik, Katarzyna
    Wojtowicz, Wojciech
    Swierkot, Jerzy
    Mielko, Karolina Anna
    Qasem, Badr
    Wielinska, Joanna
    Sokolik, Renata
    Pruss, Lukasz
    Mlynarz, Piotr
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [36] Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis
    Escudero-Vilaplana, Vicente
    Ramirez-Herraiz, Esther
    Trovato-Lopez, Nicolas
    Alanon-Plaza, Estefania
    Jose Bellini, Maria
    Herranz-Alonso, Ana
    Maria Bellon-Cano, Jose
    Morell-Baladron, Alberto
    Sanjurjo-Saez, Maria
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2012, 15 (03): : 355 - 360
  • [37] A COST UTILITY ANALYSIS OF ANTI-TNF AGENTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Adams, R. C.
    Walsh, C.
    Schmitz, S.
    Barton, P.
    Barry, M.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A312
  • [38] Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
    Kotyla, Przemyslaw J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06):
  • [39] Employer Model of Workplace Impacts of Anti-TNF Therapy for Rheumatoid Arthritis
    Birnbaum, Howard
    Pike, Crystal
    Kaufman, Rebecca
    Cifaldi, Mary
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2009, 51 (10) : 1167 - 1176
  • [40] TNF-ALPHA IN RHEUMATOID-ARTHRITIS AND PROSPECTS OF ANTI-TNF THERAPY
    MAINI, RN
    BRENNAN, FM
    WILLIAMS, R
    CHU, CQ
    COPE, AP
    GIBBONS, D
    ELLIOTT, M
    FELDMANN, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 : S173 - S175